Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study
Publication date: February 2027 Source: American Heart Journal, Volume 304 Author(s): Wojciech Wanha, Sylwia Iwanczyk, Jose Maria de la Torre Hernandez, Antoine El Khoury, Stefano De Servi, Manel Sabatè, Armando Perez de Prado, Bernardo Cortese
Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all
Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all
“Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study.” American Journal of Kidney Diseases.
@article{article3255,
title = {Single vs dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous interventions with drug-coated balloons: Design and rationale of PICCOLETO IV-EPIC 38 study},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002681?dgcid=rss_sd_all}
}